BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23281439)

  • 1. Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
    Campo E
    Mod Pathol; 2013 Jan; 26 Suppl 1():S97-S110. PubMed ID: 23281439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of molecular biology in the diagnosis of lymphoid neoplasms.
    Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
    Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New insights into the diagnosis of lymphomas.
    Soldini D; Campo E
    Ann Oncol; 2012 Sep; 23 Suppl 10():x83-8. PubMed ID: 22987998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implication of genome-wide profiling in diffuse large B-cell lymphoma and other subtypes of B-cell lymphoma.
    Iqbal J; Joshi S; Patel KN; Javed SI; Kucuk C; Aabida A; d'Amore F; Fu K
    Indian J Cancer; 2007; 44(2):72-86. PubMed ID: 17938484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic profiling for clinical decision making in lymphoid neoplasms.
    de Leval L; Alizadeh AA; Bergsagel PL; Campo E; Davies A; Dogan A; Fitzgibbon J; Horwitz SM; Melnick AM; Morice WG; Morin RD; Nadel B; Pileri SA; Rosenquist R; Rossi D; Salaverria I; Steidl C; Treon SP; Zelenetz AD; Advani RH; Allen CE; Ansell SM; Chan WC; Cook JR; Cook LB; d'Amore F; Dirnhofer S; Dreyling M; Dunleavy K; Feldman AL; Fend F; Gaulard P; Ghia P; Gribben JG; Hermine O; Hodson DJ; Hsi ED; Inghirami G; Jaffe ES; Karube K; Kataoka K; Klapper W; Kim WS; King RL; Ko YH; LaCasce AS; Lenz G; Martin-Subero JI; Piris MA; Pittaluga S; Pasqualucci L; Quintanilla-Martinez L; Rodig SJ; Rosenwald A; Salles GA; San-Miguel J; Savage KJ; Sehn LH; Semenzato G; Staudt LM; Swerdlow SH; Tam CS; Trotman J; Vose JM; Weigert O; Wilson WH; Winter JN; Wu CJ; Zinzani PL; Zucca E; Bagg A; Scott DW
    Blood; 2022 Nov; 140(21):2193-2227. PubMed ID: 36001803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
    Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
    J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of chromosomal microarray and next generation sequencing to FISH and classical cytogenetics enhances genomic profiling of myeloid malignancies.
    Mukherjee S; Sathanoori M; Ma Z; Andreatta M; Lennon PA; Wheeler SR; Prescott JL; Coldren C; Casey T; Rietz H; Fasig K; Woodford R; Hartley T; Spence D; Donnelan W; Berdeja J; Flinn I; Kozyr N; Bouzyk M; Correll M; Ho H; Kravtsov V; Tunnel D; Chandra P
    Cancer Genet; 2017 Oct; 216-217():128-141. PubMed ID: 29025587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Our changing view of the genomic landscape of cancer.
    Bell DW
    J Pathol; 2010 Jan; 220(2):231-43. PubMed ID: 19918804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
    Shingaki S; Kataoka K
    Rinsho Ketsueki; 2022; 63(9):1058-1066. PubMed ID: 36198530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating gene co-expression network in identification of cancer prognosis markers.
    Ma S; Shi M; Li Y; Yi D; Shia BC
    BMC Bioinformatics; 2010 May; 11():271. PubMed ID: 20487548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput microarray technologies: from genomics to clinics.
    Bubendorf L
    Eur Urol; 2001 Aug; 40(2):231-8. PubMed ID: 11528203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray resources for genetic and genomic studies in chicken: a review.
    Gheyas AA; Burt DW
    Genesis; 2013 May; 51(5):337-56. PubMed ID: 23468091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in lymphoma diagnosis and management.
    Iqbal J; Liu Z; Deffenbacher K; Chan WC
    Best Pract Res Clin Haematol; 2009 Jun; 22(2):191-210. PubMed ID: 19698928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.
    Chari R; Thu KL; Wilson IM; Lockwood WW; Lonergan KM; Coe BP; Malloff CA; Gazdar AF; Lam S; Garnis C; MacAulay CE; Alvarez CE; Lam WL
    Cancer Metastasis Rev; 2010 Mar; 29(1):73-93. PubMed ID: 20108112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in understanding cancer genomes through second-generation sequencing.
    Meyerson M; Gabriel S; Getz G
    Nat Rev Genet; 2010 Oct; 11(10):685-96. PubMed ID: 20847746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches to lymphoma diagnosis.
    Harris NL; Stein H; Coupland SE; Hummel M; Favera RD; Pasqualucci L; Chan WC
    Hematology Am Soc Hematol Educ Program; 2001; ():194-220. PubMed ID: 11722985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.